Gene expression profiles of FIP200-knocked out mammary tumors revealed increased expression of immune response genes, suggesting that FIP200 deficiency induces anti-tumor immune surveillance that eventually suppresses tumor progression [52]. Here, RB1CC1 is linked to neoplasm.